tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NovaBridge Biosciences Announces Positive Phase 1 Data for Ragistomig at ESMO-IO
PremiumCompany AnnouncementsNovaBridge Biosciences Announces Positive Phase 1 Data for Ragistomig at ESMO-IO
1M ago
NovaBridge’s ragistomig shows anti-tumor efficacy in Phase 1 trial
Premium
The Fly
NovaBridge’s ragistomig shows anti-tumor efficacy in Phase 1 trial
1M ago
NovaBridge to Present Ragistomig Phase 1 Data at ESMO-IO
Premium
Company Announcements
NovaBridge to Present Ragistomig Phase 1 Data at ESMO-IO
1M ago
IMAB Earnings this Week: How Will it Perform?
PremiumPre-EarningsIMAB Earnings this Week: How Will it Perform?
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100